Strawberries and Their Bioactive Compounds in Women’s Reproductive Health and Related Diseases: A Narrative Review of Preclinical and Clinical Evidence
Nutrients · 14.11.2026 · 18 (22) · 3786
DOI: 10.3390/nu18223786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 14.11.2026. Verfasst von Maya Taha und 4 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH, Howard W. and Georgeanna Seegar Jones Endowment.
Abstract (Originalsprache)
Oxidative stress, inflammation, metabolic dysregulation, and altered extracellular matrix (ECM) remodeling are involved in reproductive physiology and contribute to the pathophysiology of several gynecological disorders. Strawberry (Fragaria × ananassa) is a widely consumed fruit rich in bioactive compounds, including anthocyanins, ellagitannins, flavonols, phenolic acids, and vitamin C. Strawberries and their bioactive compounds have demonstrated a range of biological activities in experimental studies, including antioxidant, anti-inflammatory, and antifibrotic effects, suggesting potential benefits for reproductive health and selected gynecological conditions. This narrative review summarizes current evidence regarding the potential roles of strawberries and their bioactive compounds in female reproductive health and related diseases. Potential benefits for fertility, oocyte health, ovarian aging, and menopause are biologically plausible but remain supported primarily by preclinical studies and indirect clinical evidence rather than human studies directly evaluating reproductive outcomes. Preclinical studies of uterine fibroids have shown that strawberry extracts reduce fibroid cell viability and glycolysis, promote apoptosis, and modulate ECM-related pathways. A small randomized pilot trial reported reduced menstrual pain following fresh strawberry consumption in women with primary dysmenorrhea. Experimental studies further suggest antiproliferative and proapoptotic effects of strawberry-derived preparations in models of breast, ovarian, and cervical cancers, although evidence of clinical efficacy is lacking. Overall, strawberries represent a dietary source of bioactive compounds with potential relevance to women’s reproductive health and selected gynecological diseases, but further mechanistic and clinical studies are needed to establish their potential preventive or therapeutic benefits.
Förderung
- NIH
- Howard W. and Georgeanna Seegar Jones Endowment
Zitieren
APA
Taha, M., Riya, T. F., Shen, C., Segars, J. H., & Islam, M. S. (2026). Strawberries and Their Bioactive Compounds in Women’s Reproductive Health and Related Diseases: A Narrative Review of Preclinical and Clinical Evidence. Nutrients, 18(22), 3786. https://doi.org/10.3390/nu18223786
Vancouver
Taha M, Riya TF, Shen C, Segars JH, Islam MS. Strawberries and Their Bioactive Compounds in Women’s Reproductive Health and Related Diseases: A Narrative Review of Preclinical and Clinical Evidence. Nutrients. 2026;18(22):3786. doi:10.3390/nu18223786
BibTeX
@article{Taha2026,
author = {Taha, Maya and Riya, Tanzina Ferdous and Shen, Claire and Segars, James H. and Islam, Md Soriful},
title = {Strawberries and Their Bioactive Compounds in Women’s Reproductive Health and Related Diseases: A Narrative Review of Preclinical and Clinical Evidence},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3786},
doi = {10.3390/nu18223786}
}
EUVIMED